Biopolax Signs Distribution Agreement with IMCD for Home Care Applications
London, UK — January 2026
Biopolax is pleased to announce the signing of a distribution agreement with IMCD for home care applications across DACH (Germany, Austria, Switzerland), the Nordics (Denmark, Norway, Sweden, Finland, Iceland), and Türkiye. This partnership significantly expands Biopolax’s reach in key European markets and strengthens access to sustainable, plant-based ingredients for formulators in the home care segment.
Headquartered in Rotterdam, the Netherlands, IMCD is a global leader in specialty chemical distribution, with 2023 revenues of approximately €4.4 billion and over 4,700 employees, operating in more than 50 countries worldwide. The company combines a strong commercial network with advanced technical expertise, offering formulation support, regulatory guidance, and comprehensive logistics solutions.
This collaboration marks a significant step forward in Biopolax’s growth strategy and reinforces its commitment to building a strong and diversified distribution network across Europe.
Other news